rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-2-8
|
pubmed:abstractText |
Pathologic stage is the most important predictive factor of relapse in gastric cancer after curative resection. However, patients with the same stage often have different risks of relapse. Here, we investigated whether the expressions of molecular markers can supplement the current staging system in terms of relapse prediction.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cadherins,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/EGFR protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/ERBB2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 6,
http://linkedlifedata.com/resource/pubmed/chemical/PTGS2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/S100 Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/S100A4 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/SERPIN-B5,
http://linkedlifedata.com/resource/pubmed/chemical/Serpins,
http://linkedlifedata.com/resource/pubmed/chemical/Sp1 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/TP53 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1532-4192
|
pubmed:author |
pubmed-author:BangYung-JueYJ,
pubmed-author:ChoeKuk JinKJ,
pubmed-author:HeoDae SeogDS,
pubmed-author:ImSeock-AhSA,
pubmed-author:KimDong-WanDW,
pubmed-author:KimMin AMA,
pubmed-author:KimNoe KyeongNK,
pubmed-author:KimTae MinTM,
pubmed-author:KimTae-YouTY,
pubmed-author:KimWoo HoWH,
pubmed-author:KimYu JungYJ,
pubmed-author:LeeKuhn-UkKU,
pubmed-author:YangHan-KwangHK
|
pubmed:issnType |
Electronic
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
152-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18259945-Adult,
pubmed-meshheading:18259945-Aged,
pubmed-meshheading:18259945-Cadherins,
pubmed-meshheading:18259945-Cyclin-Dependent Kinase Inhibitor p27,
pubmed-meshheading:18259945-Cyclooxygenase 2,
pubmed-meshheading:18259945-Female,
pubmed-meshheading:18259945-Humans,
pubmed-meshheading:18259945-Male,
pubmed-meshheading:18259945-Middle Aged,
pubmed-meshheading:18259945-Mitogen-Activated Protein Kinase 6,
pubmed-meshheading:18259945-Neoplasm Recurrence, Local,
pubmed-meshheading:18259945-Neoplasm Staging,
pubmed-meshheading:18259945-Prognosis,
pubmed-meshheading:18259945-Receptor, Epidermal Growth Factor,
pubmed-meshheading:18259945-Receptor, erbB-2,
pubmed-meshheading:18259945-S100 Proteins,
pubmed-meshheading:18259945-Serpins,
pubmed-meshheading:18259945-Sp1 Transcription Factor,
pubmed-meshheading:18259945-Stomach Neoplasms,
pubmed-meshheading:18259945-Tumor Markers, Biological,
pubmed-meshheading:18259945-Tumor Suppressor Protein p53
|
pubmed:year |
2008
|
pubmed:articleTitle |
Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
|
pubmed:affiliation |
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|